Assignee
MERSANA THERAPEUTICS INC
US·33 granted patents·28 pending applications·356 citations·filing 2011–2025
Top patents by PatentIndex Score
61 records- 0198US8815226B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2012·Granted Aug 26, 2014·54 cites·8 claims
- 0297US9144615B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Sep 29, 2015·19 cites·22 claims
- 0397US8821850B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Sep 2, 2014·20 cites·18 claims
- 0496US9738720B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·10 cites·30 claims
- 0596US8349308B2Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2011·Granted Jan 8, 2013·141 cites·31 claims
- 0695US11155567B2Sting agonist compounds and methods of useMERSANA THERAPEUTICS INC·Filed 2020·Granted Oct 26, 2021·6 cites·14 claims
- 0795US8808679B2Auristatin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2013·Granted Aug 19, 2014·26 cites·20 claims
- 0894US10947317B2NaPi2b-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Mar 16, 2021·9 cites·15 claims
- 0994US9555112B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2015·Granted Jan 31, 2017·13 cites·42 claims
- 1093US10143695B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·7 cites·25 claims
- 1193US9254339B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Feb 9, 2016·16 cites·20 claims
- 1292US12156870B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Dec 3, 2024·1 cites·30 claims
- 1392US9770519B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·2 cites·21 claims
- 1489US11135307B2Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2017·Granted Oct 5, 2021·4 cites·8 claims
- 1589US2025066489A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1687US11939343B2Sting agonist compounds and methods of useMERSANA THERAPEUTICS INC·Filed 2021·Granted Mar 26, 2024·1 cites·11 claims
- 1786US10660901B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2018·Granted May 26, 2020·2 cites·25 claims
- 1885US11596694B2Compositions and methods for predicting response to NaPi2b-targeted therapyMERSANA THERAPEUTICS INC·Filed 2018·Granted Mar 7, 2023·4 cites·8 claims
- 1985US10603386B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2017·Granted Mar 31, 2020·1 cites·18 claims
- 2083US10526294B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Jan 7, 2020·5 cites·29 claims
- 2182US2023265197A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2281US9872918B2Hydroxyl-polymer-drug-protein conjugatesMERSANA THERAPEUTICS INC·Filed 2013·Granted Jan 23, 2018·2 cites·14 claims
- 2380US12440576B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 2480US9808528B2Protein-polymer-drug conjugates and methods of using sameMERSANA THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·2 cites·20 claims
- 2580US2025352662A1Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2679US9943609B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2016·Granted Apr 17, 2018·2 cites·20 claims
- 2778US9849191B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Dec 26, 2017·3 cites·19 claims
- 2878US2024382611A1Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2978US2025011339A1Sting agonist compounds and methods of useMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3077US11407825B2NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2019·Granted Aug 9, 2022·3 cites·12 claims
- 3177US10226535B2Auristatin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2013·Granted Mar 12, 2019·2 cites·19 claims
- 3274US11518812B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2019·Granted Dec 6, 2022·0 cites·14 claims
- 3374US10772971B2Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Granted Sep 15, 2020·1 cites·41 claims
- 3472US2024148887A1Site specific antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3571US2021106690A1Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3671US2024269306A1B7h4-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3769US11964025B2Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2021·Granted Apr 23, 2024·0 cites·16 claims
- 3869US2017313778A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3969US2022378749A1Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4069US2023355787A1Compositions and methods for predicting response to napi2b-targeted therapyMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4167US11964024B2B7H4-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·0 cites·30 claims
- 4267US11786605B2Site specific antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·0 cites·8 claims
- 4364US10537645B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·0 cites·20 claims
- 4463US2016022829A1Tubulysin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4561US2021301031A1Napi2b-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4660US2023398229A1Antibody drug conjugates comprising sting agonists, combinations and methods of useMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4759US2014017265A1Terminally Modified Polymers and Conjugates ThereofMERSANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4858US2018243427A1Tubulysin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4957US2022332815A1NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOFMERSANA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 5054US2024050585A1B7-h4-targeted antibody-drug conjugates for the treatment of cancerMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →